Farallon Capital Management’s Vaxcyte PCVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-28,000	Closed	-$3.2M	–	160
2024 Q3	$3.2M	Sell	28,000 -262,000	-90%	-$29.9M	0.01%	92
2024 Q2	$21.9M	Sell	290,000 -87,400	-23%	-$6.6M	0.09%	67
2024 Q1	$25.8M	Buy	377,400 +374,000	+11,000%	+$25.5M	0.11%	62
2023 Q4	$214K	Buy	+3,400	New	+$214K	﹤0.01%	125